AzTrials
AzTrials

ArthrosisNCT01474031

Prospective Study Deltamotion - DAA THA Study

An observational study of Arthrosis, run by Universitaire Ziekenhuizen KU Leuven at 1 site in Belgium.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

1. Introduction Few gait analytical data are available concerning the Direct Anterior Approach (DAA) in total hip arthroplasty (THA). All the studies have focused on immediate post-operative recovery. Read more about this study

Who is it for?
Ages 20 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Arthrosis
What is being tested?
Biomechanics
How many people
29 participants
Where
1 siteBelgium
Study dates
Oct 2011to Jul 2013
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: 20 DAA subjects

Who may be able to join

  • Age: 20-75 years
  • BMI: < 30kg/m2
  • Diagnosis: unilateral primary and secondary osteoarthritis treated with the Deltamotion THA with a Corail stem

Who cannot join

  • Osteoarthritis other joints and low back impairment
  • LLD > 5mm

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • UZ Pellenberg

    Leuven, 3000

Other trials in Belgium

About this study

  1. Introduction Few gait analytical data are available concerning the Direct Anterior Approach (DAA) in total hip arthroplasty (THA). All the studies have focused on immediate post-operative recovery. These studies have in general some important shortcomings in order to accurately evaluate the biomechanics of the replaced hip joint. None of the published reports have reported on consecutive intervals of pre-op - 6w - 3m - 6m - 12m. This is of interest as we know that recovery with other approaches takes >1 year. It might be that the DAA approach leads to normal gait patterns at 3m or 6m and that these patterns do not differ from the normal pattern or at >1y post-op. None of the reports utilized out-of-plane movements such as coming down or up stairs or squads. Utilizing trunk markers is frequently not done but it is important to evaluate the centre of mass position during gait. Very few studies utilize kinetic data, which are important in order to thoroughly evaluate the biomechanics and loading of the hip. And maybe most importantly, the biomechanical effect of the diameter of the articulating surface on gait parameters following the DAA has never been evaluated. One of the most important advantages of the DAA is the muscle sparing aspect and the presumption that the femoral anatomy and biomechanics can be more accurately and precisely restored. If the diameter of the articulating surface has then also been reconstructed to the almost anatomical diameter, we can assume that this should be the most optimal reconstruction of the hip joint currently available. This could lead to early return to normal gait, to optimal joint loading and a minimal amount of stress shielding of the femoral bone. The aim of this project is to prospectively analyse the biomechanics of the hip joint of a THA with a Deltamotion articulating surface utilizing the Direct Anterior Approach.
  2. Materials and Methods Hypothesis: The temporo-spatial parameters (velocity, cadence, step length, and stride length) and gait kinematic and kinetic data (external hip and knee muscle moments) are not significantly different between the study and control group at the evaluated time intervals indicating normal or near normal gait patterns in the early post-operative recovery phase.
Read the detailed description

Estimated inclusion time: 1 July 2011 - 31 December 2013 Cohorts: 20 DAA subjects - 20 control subjects

Assessments:

  • Time interval: pre-op - 3m - 6m - 12m
  • Gait analysis with surface EMG and trunk markers:
  • Unipodal standing: 3 trials Right and 3 trials Left on FP
  • Level walking: 3 trials Right and 3 trials Left on FP
  • Chair rise: 3 trials, both legs on FP
  • Stair ascent: 3 trials Right and 3 trials Left on first FP
  • Stair descent: 3 trials Right and 3 trials Left on first FP
  • Squat: 3 trials, both legs on FP
  • Bipodal squat: 3 trials Right and 3 trials Left on FP
  • Functional scores (HHS, UCLA, HOOS, SF-36)
Conditions
Arthrosis
Being tested
Biomechanics
Keywords
total hip arthroplasty, biomechanics, direct anterior approach
Medical subject headings
Osteoarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BiomechanicsOther

    • Time interval: pre-op - 3m - 6m - 12m
    • Assessment of all subjects:
    • XR
    • Gait analysis with surface EMG and trunk markers:
    • Unipodal standing: 3 trials Right and 3 trials Left on FP
    • Level walking: 3 trials Right and 3 trials Left on FP
    • Chair rise: 3 trials, both legs on FP
    • Stair ascent: 3 trials Right and 3 trials Left on first FP
    • Stair descent: 3 trials Right and 3 trials Left on first FP
    • Squat: 3 trials, both legs on FP
    • Bipodal squat: 3 trials Right and 3 trials Left on FP
    • Functional scores (HHS, UCLA, HOOS, SF-36)
Study groups in NCT01474031
Study groupRoleWhat they receive
20 DAA subjects20 DAA subjects: THA with a Deltamotion articulating surface utilizing the Direct Anterior Approach
Receives: Other: Biomechanics
Control grouphealthy volunteers
Receives: Other: Biomechanics

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. biomechanics

    prospectively analyse the biomechanics of the hip joint of a THA with a Deltamotion articulating surface utilizing the Direct Anterior Approach

    Measured: 0.5 year

Secondary outcomes (1)
  1. bone remodelling

    assess the femoral bone remodelling around the fully coated Corail stem over the first year post-operatively.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Nov 2011 (estimated)
  2. Study startOct 2011
  3. Primary completionJul 2013
  4. Study completionJul 2013

Why it stopped: Main investigator has left the department and therefore the study had ended

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
29 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01474031
Sponsor's protocol ID
s52629
Status last verified
Aug 2011
First submitted
7 Nov 2011
Last updated
18 Nov 2020
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Arthrosis, run by Universitaire Ziekenhuizen KU Leuven at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 18 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Main investigator has left the department and therefore the study had ended). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

biomechanics (time frame: 0.5 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in